VIRTUAL EVENT | Member’s Webinar
- Cross state licensure for the following scenarios:
- Patient who originate in person but are traveling
- Patients who originate in person but then move to another state
- Patient who originate out-of-state
- Patient who travels to initiate care in the state the prescriber is in and then return to their state
- Impacted by writing script or diagnosing and treating versus providing consultive/educational communications
- Medical malpractice coverage for patients whose stated residence is outside the state of healthcare professionals’ office/practice/insurance
- Electronic communication consent/risk mitigation for virtual patients (out of state).
- CURES Act compliance
- Does the provider need to have a license and DEA in the state the prescription is written or the state the patient lives in
- Can controlled substances i.e. testosterone be prescribed via telehealth
- NEW YORK: testosterone is C2 i.e. no telehealth in New York?
- CALIFORNIA: whether publication of medical educational information that is non-allopathic (outside of scientific community consensus) triggers exposure with laws intended to regulate medical information dissemination that allegedly poses public health risks
- NON-SUBSCRIPTION PRACTICES: Are virtual consults for cash medicare/Medicaid compliant or not and why? Are there business and compliance reasons to focus more on subscription pricing?
- Update on pending telehealth legislation